Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TXA in Burn Wound Surgery
NCT02753816Terminated
- Sponsor
- Corewell Health
- Start
- Apr 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in burn injury comparing Tranexamic Acid with Placebo (2 arms). Primary endpoints: Intraoperative Blood Loss in mL and Blood Transfusion Rates. Started Apr 2016; status: terminated.
02
Drugs
tranexamic acid
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT02753816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02753816.